Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis

Vaccine

Volumn 24, Issue 13, 2006, Pages 2409-2416

  Tewary, Poonam ^a   Saxena, Shailendra ^a   Madhubala, Rentala ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

IL 12 DNA vaccine; L. donovani; rORFF protein vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; OPEN READING FRAME F PROTEIN; PROTEIN P35; PROTEIN P40; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENETIC CODE; HUMORAL IMMUNITY; IMMUNITY; IMMUNOMODULATION; LEISHMANIA DONOVANI; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMASTIGOTE; SPLEEN; SPLEEN CELL; TH1 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 33344475047     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.058     Document Type: Article

References (35)

1. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1199
2. S.L. Reiner, and R.M. Locksley The regulation of immunity to Leishmania major Annu Rev Immunol 13 1995 151 177
3. P. Scott, and J.P. Farrell Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major Chem Immunol 70 1998 60 80
4. P.M. Kaye, A.J. Curry, and J.M. Blackwell Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis J Immunol 146 1991 2763 2770
5. G.D. Miralles, M.Y. Stoeckle, D.F. McDermott, F.D. Finkelman, and H.W. Murray Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis Infect Immun 62 1994 1058 1063
6. M.E. Wilson, M. Sandor, A.M. Blum, B.M. Young, A. Metwali, and D. Elliott Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi J Immunol 156 1996 2231 2239
7. H.W. Murray Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis J Infect Dis 175 1997 1477 1479
8. C.S. Hsieh, S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy Development of Th1 CD41 T cells through IL-12 produced by Listeria-induced macrophages Science 260 1993 547 549
9. R. Manetti, P. Parronchi, M.G. Giudizi, M.P. Piccinni, E. Maggi, and G. Trinchieri Natural killer cell stimulatory factor interleukin-12 (IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells J Exp Med 177 1993 1199 1204
10. R. Manetti, F. Gerosa, M.G. Giudizi, R. Biagiotti, P. Parronchi, and M.P. Piccinni Interleukin-12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones J Exp Med 179 1994 1273 1283
11. + T cells to enhance priming for interferon Υ production and diminishes interleukin-4 inhibition of such priming Proc Natl Acad Sci USA 90 1993 10188 10192
12. C.-Y. Wu, C. Deumeure, M. Kiniwa, M. Gately, and G. Delespesse IL-12 induces the production of IFN-g by neonatal human CD4 T cells J Immunol 151 1993 1938 1949
13. F.P. Heinzal, R.M. Rerko, F. Ahmad, and E. Pearlman Endogenous IL-12 is required for the control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice J Immunol 155 1995 730 739
14. F. Mattner, J. Magram, J. Ferrante, P. Launois, K. Di Padova, and R. Behin Genetically resistant mice lacking interleukin-12 are susceptible to infection with L. major and mount polarized Th2 responses Eur J Immunol 26 1996 1553 1559
15. J.A. Louis, H. Himmelrich, C. Parra-Lopez, F. Tacchini-Cottier, and P. Launois Regulation of protective immunity against Leishmania major in mice Curr Opin Immunol 10 1998 459 464
16. J.P. Sypek, C.L. Chung, S.E. Mayor, J.M. Subramanyam, S.J. Goldman, and D.S. Sieberth Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response J Exp Med 180 1993 783 793
17. H.W. Murray, and J. Hariprashad Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis Infect Immun 70 1995 1627 1630
18. A. Ghosh, R. Madhubala, P.J. Myler, and K.D. Stuart Leishmania donovani: characterization and expression of ORFF, a gene amplified from the LD1 locus Exp Parasitol 93 1999 225 230
19. P.J. Myler, G.M. Venkataraman, M.J. Lodes, and K.D. Stuart A frequently amplified region in Leishmania contains a gene that is conserved in prokaryotes and eukaryotes Gene 148 1994 187 193
20. C.A. Tripp, W.A. Wisdom, P.J. Myler, and K.D. Stuart A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5 kb LD1 sequence and encodes numerous transcripts Mol Biochem Parasitol 55 1992 39 50
21. V.S. Raj, A. Ghosh, V.S. Dole, and R. Madhubala Serodiagnosis of leishmaniasis with recombinant ORFF antigen Am J Trop Med Hyg 61 3 1999 482 487
22. V.S. Dole, V.S. Raj, A. Ghosh, R. Madhubala, P.J. Myler, and K.D. Stuart Immunization with recombinant LD1 antigens protects against experimental leishmaniasis Vaccine 19 2000 423 430
23. L. Proudfoot, A.V. Nikolaev, G.J. Feng, W.Q. Wei, M.A. Ferguson, and J.S.F. Brimacombe Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages Proc Natl Acad Sci USA 93 1996 10984 10989
24. B. Sukumaran, P. Tewary, S. Saxena, and R. Madhubala Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani Vaccine 21 2003 1292 1299
25. P. Tewary, B. Sukumaran, S. Saxena, and R. Madhubala Immunostimulatory oligodeoxynucleotides are potent enhancers of specific immunity in mice immunized with recombinant ORFF leishmanial antigen Vaccine 22 2004 3053 3060
26. F.P. Heinzel, D.S. Schoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately Recombinant interleukin-12 cures mice infected with Leishmania major J Exp Med 177 1993 1505 1509
27. T. Scharton-Kersten, L.C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis J Immunol 154 1995 5320 5330
28. M.D. Sadick, F.P. Heinzel, B.J. Holaday, R.T. Pu, R.S. Dawkins, and R.M. Locksley Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T cell-dependent, interferon-independent mechanism J Exp Med 171 1990 115 127
29. V. Julia, M. Rassoulzadegan, and N. Glaichenhaus Resistance to Leishmania major induced by tolerance to a single antigen Science 274 1996 421 423
30. L.C. Afonso, T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott The adjuvant effect of interleukin-12 in a vaccine against Leishmania major Science 263 1994 235 237
31. L. Stobie, S. Gurunathan, C. Prussin, D.L. Sacks, N. Glaichenhaus, and C.Y. Wu The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge Proc Natl Acad Sci USA 97 2000 8427 8432
32. S. Gurunathan, C. Prussin, D.L. Sacks, and R.A. Seder Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection Nat Med 4 1998 1409 1415
33. P. Tewary, M. Jain, M. Sahani, S. Saxena, and R. Madhubala A heterologous prime boost vaccine regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis in murine mouse model J Infect Dis 191 12 2005 2130 2137
34. H.L. Davis, R. Weeranta, T.J. Waldshmidt, L. Tygrett, J. Schorr, and M. Krieg CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 160 1998 870 876
35. T.W. Salcedo, L. Azzoni, S.F. Wolf, and B. Persussia Modulation of perforin and granzyme messenger RNA expression in human natural killer cells J Immunol 151 1993 2511 2520